Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results